3',4'-Methylenedioxy-α-pyrrolidinopropiophenone

Source: Wikipedia, the free encyclopedia.
3',4'-Methylenedioxy-α-pyrrolidinopropiophenone
Clinical data
Routes of
administration		By mouth, insufflation, vaporization, IV, rectal, sublingual
Legal status
Legal status
Pharmacokinetic data
MetabolismHepatic[1][2]
ExcretionPrimarily urine (renal)
Identifiers
  • (RS)-1-(3,4-methylenedioxyphenyl)-2-(1-pyrrolidinyl)-1-propanone
JSmol)
ChiralityRacemic mixture
  • c3c1OCOc1ccc3C(=O)C(C)N2CCCC2
  • InChI=1S/C14H17NO3/c1-10(15-6-2-3-7-15)14(16)11-4-5-12-13(8-11)18-9-17-12/h4-5,8,10H,2-3,6-7,9H2,1H3
  • Key:NIYQOTCYXGXMPI-UHFFFAOYSA-N

3',4'-Methylenedioxy-α-pyrrolidinopropiophenone (MDPPP) is a

ecstasy (MDMA) pills.[3] It shares a similar chemical structure with α-PPP and MDPV,[4][1][2] and has been shown to have reinforcing effects in rats.[5]

Metabolism

MDPPP appears to have a similar metabolic fate as

MDPV.[2]

Legal Status

As of October 2015[update] MDPPP is a controlled substance in China.[6]

See also

References

  1. ^
    PMID 15975043
    .
  2. ^
    S2CID 28207896
    .
  3. PMID 12906913
    .
  4. S2CID 9255084
    .
  5. PMID 28811192
    .
  6. ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.
Retrieved from "https://en.wikipedia.org/w/index.php?title=3%27,4%27-Methylenedioxy-α-pyrrolidinopropiophenone&oldid=1187396024"